Who owns MAPLIGHT THERAPEUTICS INC COM?
- Ticker: MPLT
- CUSIP Number: 56565p103
Tip: Access positions for across all investors
Analyze quarterly positions in Maplight Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Maplight Therapeutics stock
Who bought or sold MAPLIGHT THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Novo A/S | 3.7M | $75M | 0% | Mar 2026 |
|
| Fcpm Iii Services B.v. | 3.2M | $66M | 0% | Mar 2026 |
|
| Goldman Sachs Group | 2.0M | $41M | 3% | Mar 2026 |
|
| BlackRock | 1.3M | $27M | 22% | Mar 2026 |
|
| Blue Owl Capital Holdings | 1.0M | $21M | 208% | Mar 2026 |
|
| Nan Fung Group Holdings | 971k | $20M | 0% | Mar 2026 |
|
| 5AM Venture Management | 950k | $19M | 0% | Mar 2026 |
|
| Sanofi | 912k | $19M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 720k | $15M | 100% | Mar 2026 |
|
| Pivotal bioVenture Partners Investment Advisor | 611k | $12M | 0% | Mar 2026 |
|
| Velan Capital Investment Management | 493k | $10M | -6% | Mar 2026 |
|
| Geode Capital Management | 481k | $9.8M | 24% | Mar 2026 |
|
| Siren | 450k | $9.1M | 0% | Mar 2026 |
|
| Vestal Point Capital | 420k | $8.5M | 9% | Mar 2026 |
|
| ADAR1 Capital Management | 375k | $7.6M | 100% | Mar 2026 |
|
| Baker Bros. Advisors | 365k | $7.4M | 0% | Mar 2026 |
|
| State Street Corporation | 339k | $6.9M | 48% | Mar 2026 |
|
| Freestone Grove Partners | 314k | $6.4M | 71% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 268k | $5.4M | 81% | Mar 2026 |
|
| RA Capital Management | 248k | $5.0M | 100% | Mar 2026 |
|
| UBS Group | 237k | $4.8M | 1193% | Mar 2026 |
|
| FMR | 205k | $4.2M | 22522% | Mar 2026 |
|
| Board of Trustees of The Leland Stanford Junior University | 199k | $4.1M | 0% | Mar 2026 |
|
| Superstring Capital Management | 192k | $3.9M | 100% | Mar 2026 |
|
| DAFNA Capital Management | 171k | $3.5M | 19% | Mar 2026 |
|
| Charles Schwab Investment Management | 161k | $3.3M | 16% | Mar 2026 |
|
| Northern Trust | 146k | $3.0M | 22% | Mar 2026 |
|
| Lazard Asset Management | 142k | $2.9M | -32% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 131k | $2.7M | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 113k | $2.3M | 100% | Mar 2026 |
|
| Polygon Management | 112k | $2.3M | -32% | Mar 2026 |
|
| Seven Grand Managers | 100k | $2.0M | 0% | Mar 2026 |
|
| Stempoint Capital | 100k | $2.0M | 0% | Mar 2026 |
|
| Burkehill Global Management | 75k | $1.5M | 0% | Mar 2026 |
|
| Henderson Group | 55k | $1.1M | 100% | Mar 2026 |
|
| TD Asset Management | 48k | $971k | 29% | Mar 2026 |
|
| Wellington Management Company | 46k | $939k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 40k | $802k | 10% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 37k | $758k | 980% | Mar 2026 |
|
| Tudor Investment Corporation | 37k | $747k | -23% | Mar 2026 |
|
| Morgan Stanley | 31k | $620k | 31% | Mar 2026 |
|
| Nuveen | 23k | $469k | 14% | Mar 2026 |
|
| Rhumbline Advisers | 20k | $414k | 49% | Mar 2026 |
|
| Ghisallo Capital Management | 20k | $407k | 0% | Mar 2026 |
|
| Bank of America Corporation | 19k | $384k | 100% | Mar 2026 |
|
| Market Street Wealth Management Advisors | 14k | $287k | 100% | Mar 2026 |
|
| Two Sigma Investments | 14k | $287k | 100% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 14k | $278k | 15% | Mar 2026 |
|
| Invesco | 12k | $249k | -6% | Mar 2026 |
|
| Walleye Trading Advisors | 12k | $235k | -1% | Mar 2026 |
|
| XTX Topco | 10k | $209k | 100% | Mar 2026 |
|
| LMR Partners | 10k | $203k | 0% | Mar 2026 |
|
| MetLife Investment Advisors | 9.8k | $199k | 0% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 9.1k | $184k | 16% | Mar 2026 |
|
| Vanguard Global Advisers | 8.4k | $171k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 7.2k | $146k | -62% | Mar 2026 |
|
| Barclays | 5.8k | $118k | -78% | Mar 2026 |
|
| New York State Common Retirement Fund | 5.3k | $108k | 0% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 4.0k | $81k | 0% | Mar 2026 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.0k | $61k | 0% | Mar 2026 |
|
| Tower Research Capital | 1.9k | $39k | -33% | Mar 2026 |
|
| Legal & General Group | 1.8k | $37k | 9% | Mar 2026 |
|
| Summit Investment Advisors | 1.4k | $28k | 0% | Mar 2026 |
|
| Russell Investments | 1.3k | $27k | 0% | Mar 2026 |
|
| California State Teachers Retirement System | 1.1k | $22k | 2% | Mar 2026 |
|
| Citigroup | 960.00 | $20k | 100% | Mar 2026 |
|
| SBI Securities | 557.00 | $11k | -8% | Mar 2026 |
|
| Sterling Capital Management | 370.00 | $7.5k | -29% | Mar 2026 |
|
| GAMMA Investing | 123.00 | $4.4k | 31% | Jun 2026 |
|
| Farther Finance Advisors | 120.00 | $2.5k | 0% | Mar 2026 |
|
| CWM | 57.00 | $1.2k | 100% | Mar 2026 |
|
| Versant Capital Management | 50.00 | $1.8k | 0% | Jun 2026 |
|
| Root Financial Partners | 28.00 | $568.999200 | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 12.00 | $243.999600 | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 6.00 | $121.999800 | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 6.00 | $121.500000 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 5.00 | $20.000000 | 100% | Mar 2026 |
|
| True Wealth Design | 3.00 | $60.999900 | 100% | Mar 2026 |
|
Who sold out of Maplight Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Perceptive Advisors | Dec 2025 | 550k | $9.7M |
| Jain Global | Dec 2025 | 328k | $5.8M |
| Citadel Advisors | Dec 2025 | 190k | $3.3M |
| Ameriprise Financial | Dec 2025 | 67k | $1.2M |
| Diadema Partners | Dec 2025 | 64k | $1.1M |
| OrbiMed Advisors | Dec 2025 | 56k | $952k |
| Marshall Wace | Dec 2025 | 40k | $697k |
| Persistent Asset Partners | Dec 2025 | 22k | $382k |
| Oxford Asset Management | Dec 2025 | 18k | $312k |
| Millennium Management | Dec 2025 | 14k | $245k |
| Lynx1 Capital Management | Dec 2025 | 14k | $237k |
| Amalgamated Bank | Dec 2025 | 530.00 | $9.0k |
| Federation des caisses Desjardins du Quebec | Dec 2025 | 500.00 | $8.8k |